Senior insider sale
Chief Commercial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$1.7K
99.00 shares
What this filing means
ERDOGAN-TRINKAUS IPEK plans to sell 99.00 shares of ETON PHARMACEUTICALS, INC. valued at approximately $1.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001974078-25-000477
Officer· Chief Commercial Officer
Since Dec 2024
99.00
Shares to sell
$1.7K
Approx. market value
99.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Grant
Grant
12/11/2025
99.00Total acquired99.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2025 | Grant Grant | 99.00 | — |
| Total | 99.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
99.00
Market value
$1.7K
12/12/2025
Total
Units
99.00
Value
$1.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 99.00 | $1.7K | NASDAQ | Planned |
| Total | 99.00 | $1.7K | ||